NASDAQ: LIXT
Lixte Biotechnology Holdings Inc Stock Ownership - Who owns Lixte Biotechnology Holdings?

Insider buying vs selling

Have Lixte Biotechnology Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LIXT insiders and whales buy or sell their stock.

LIXT Shareholders

What type of owners hold Lixte Biotechnology Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John S. Kovach27.00%1,540,183$4.34MInsider
Glenn Krinsky25.86%1,474,998$4.16MInsider
Gil Schwartzberg20.62%1,176,388$3.32MInsider
Robert 1. Greenberg17.43%994,299$2.80MInsider
Scotia Capital Inc4.54%258,713$729.57kInstitution
Renaissance Technologies LLC1.88%107,500$303.15kInstitution
Philip F. Palmedo1.88%107,056$301.90kInsider
Federation Des Caisses Desjardins Du Quebec1.64%93,380$263.33kInstitution
Vanguard Group Inc1.31%74,944$211.34kInstitution
Stephen J. Forman1.31%74,804$210.95kInsider

1 of 3

LIXT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIXT12.07%87.93%
QCLS9.32%90.68%
INAB14.08%85.92%Net BuyingNet Buying
FBLG6.54%9.46%Net BuyingNet Buying
ALLR8.17%13.31%Net Selling

Lixte Biotechnology Holdings Stock Ownership FAQ

Who owns Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings (NASDAQ: LIXT) is owned by 13.24% institutional shareholders, 96.44% Lixte Biotechnology Holdings insiders, and 0.00% retail investors. John S. Kovach is the largest individual Lixte Biotechnology Holdings shareholder, owning 1.54M shares representing 27.00% of the company. John S. Kovach's Lixte Biotechnology Holdings shares are currently valued at $4.48M.

If you're new to stock investing, here's how to buy Lixte Biotechnology Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.